Evidence map›Paper›PMID 33540785›Full record

ArticleJournal of personalized medicine2021

Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada.

Cynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, Michel Dorval, Jocelyne Chiquette, Laurence Eloy, Annie Turgeon, Laurence Lambert-Côté, Jean-Sébastien Paquette, Emmanuelle Lévesque and 13 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Acceptability of risk stratification within population-based cancer screening from the perspective of the general public: A mixed-methods systematic review.Health expectations : an international journal of public participation in health care and health policy · 2023
    Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Awareness, knowledge, and attitudes toward polygenic risk scores for breast cancer in multiethnic high-risk cohorts of women.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Cynthia Mbuya BiengeCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.
Nora PashayanDepartment of Applied Health Research, Institute of Epidemiology and Healthcare, University College, London WC1E 6BT, UK.ORCID 0000-0003-0843-2468
Jennifer D BrooksDalla Lana School of Public Health Science, University of Toronto, Toronto, ON M5S 1A1, Canada.
Michel DorvalCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.ORCID 0000-0002-3207-8211
Jocelyne ChiquetteCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.
Laurence EloyQuébec Cancer Program, Ministère de la Santé et des Services Sociaux, Quebec City, QC G1S 2M1, Canada.
Annie TurgeonCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.
Laurence Lambert-CôtéCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.
Jean-Sébastien PaquetteDépartement de Médecine Familiale et de Médecine d'Urgence, Université Laval, Quebec City, QC G1V 4G2, Canada.ORCID 0000-0002-9524-6761
Emmanuelle LévesqueCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.ORCID 0000-0002-4618-6635
Julie HaganCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.ORCID 0000-0001-7647-5246
Meghan J WalkerDalla Lana School of Public Health Science, University of Toronto, Toronto, ON M5S 1A1, Canada.ORCID 0000-0003-4189-7507
Julie LapointeCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.
Gratien DalpéCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.ORCID 0000-0002-3049-3315
Palmira Granados Granados MorenoCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.ORCID 0000-0002-0501-9312
Kristina BlackmoreOntario Health, Cancer Care Ontario, Toronto, ON M5G 2L3, Canada.
Michael WolfsonSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1G 5Z3, Canada.
Yann JolyCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.
Mireille BroedersRadboud Institute for Health Sciences, Radboud University Medical Center, 525 EZ Nijmegen, The Netherlands.ORCID 0000-0002-8741-8148
Bartha M KnoppersCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.ORCID 0000-0001-7004-2722
Anna M ChiarelliDalla Lana School of Public Health Science, University of Toronto, Toronto, ON M5S 1A1, Canada.
Jacques SimardCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.
Hermann NabiCHU de Québec-Université Laval Research Center, Quebec City, QC G1V 4G2, Canada.

Funding

ALTERNATIVE PATHWAYS OF T CELL ACTIVATIONK08AR002017 · NIAMS · VANDERBILT UNIVERSITY · PI BYRD, VICTOR M · 1998 to 2002
$348k
CHU de Quebec Foundation CHU de Quebec FoundationCIHR LSARP-2017Genome Canada LSARP-2017Genome Quebec LSARP-2017Ontario Research Fund Ontario Research FundQuebec Breast Cancer Foundation Quebec Breast Cancer Foundation
6 · The paper itself

Abstract

Risk-stratified screening for breast cancer (BC) is increasingly considered as a promising approach. However, its implementation is challenging and needs to be acceptable to women. We examined Canadian women's attitudes towards, comfort level about, and willingness to take part in BC risk-stratified screening. We conducted an online survey in women aged 30 to 69 years in four Canadian provinces. In total, 4293 women completed the questionnaire (response rate of 63%). The majority of women (63.5% to 72.8%) expressed favorable attitudes towards BC risk-stratified screening. Most women reported that they would be comfortable providing personal and genetic information for BC risk assessment (61.5% to 67.4%) and showed a willingness to have their BC risk assessed if offered (74.8%). Most women (85.9%) would also accept an increase in screening frequency if they were at higher risk, but fewer (49.3%) would accept a reduction in screening frequency if they were at lower risk. There were few differences by province; however, outcomes varied by age, education level, marital status, income, perceived risk, history of BC, prior mammography, and history of genetic test for BC (all

Indexed as

breast cancerpopulation surveyprecision preventionrisk-stratified screeningwomen’s per-spectives

Identifiers

PMID33540785
PMCPMC7912955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.